Author: Dr. David Lowemann

Study finds widespread exposure to hormone-disrupting chemical during pregnancy

Researchers link zearalenone levels to diet quality and call for further study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in […]

Published on October 19, 2024

Journalists Address Opioid Settlements, Undiagnosed ADHD, and a Georgia Chemical Fire

KFF Health News senior correspondent Aneri Pattani discussed Ohio’s $2 billion in opioid settlement funds on WOSU Public Media’s “All Sides with Anna Staver” on Oct. 16. Click here to hear Pattani on WOSU Public Media’s “All Sides with Anna Staver” Read Pattani’s coverage of opioid settlements in “Payback: Tracking the Opioid Settlement Cash” KFF […]

Published on October 19, 2024

Walmart Reaches Settlement Over Handling of Opioids

Walmart said Friday it has reached a proposed settlement pact related to three lawsuits filed by shareholders on behalf of the company over the handling of prescription opioids. According to the terms of the settlement that were disclosed in a regulatory filing, insurance … Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on October 18, 2024